← All trials
NCT02367248
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2015
- Primary completion
- Dec 1, 2016
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 180
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Capital Medical UniversityLead sponsor
- Capital Medical UniversityReponsible party - principal investigator
- Beijing Fangshan District Liangxiang HospitalCollaborator
- Peking UniversityCollaborator
- Capital Medical UniversityCollaborator
- China Academy of Chinese Medical SciencesCollaborator
- China Medical UniversityCollaborator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.